Related content

Clinical outcome in diffuse large B-cell lymphoma with hepatitis C virus infection in the rituximab era: A single center experience

By Nishikawa Hiroki   Tsudo Mitsuru   Osaki Yukio  

Oncology Reports, Vol. 28, Iss. 3, 2012-09 ,pp. : 835-840

Spandidos Publications

Access to resources Recommend Favorite

Clinical analysis and prognostic significance of hepatitis B virus infections for diffuse large B-cell lymphoma with or without rituximab therapy

By                          

Experimental and Therapeutic Medicine, Vol. 6, Iss. 1, 2013-01 ,pp. : 109-114

Spandidos Publications

Access to resources Recommend Favorite

Association of cytotoxic T-lymphocyte antigen 4 genetic polymorphism, hepatitis C viral infection and B-cell non-Hodgkin lymphoma: an Egyptian study

By Khorshied Mervat Mamdooh   Gouda Heba Mahmoud   Khorshid Ola M. Reda  

Leukemia and Lymphoma, Vol. 55, Iss. 5, 2014-05 ,pp. : 1061-1066

Informa Healthcare

Access to resources Recommend Favorite

A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival

By Kinch Amelie   Baecklund Eva   Backlin Carin   Ekman Tor   Molin Daniel   Tufveson Gunnar   Fernberg Pia   Sundström Christer   Pauksens Karlis   Enblad Gunilla  

Acta Oncologica, Vol. 53, Iss. 5, 2014-05 ,pp. : 669-679

Informa Healthcare

Access to resources Recommend Favorite

Influence of cytotoxic T lymphocyte-associated antigen 4 polymorphisms on the outcomes of hepatitis B virus infection

By                

Molecular Medicine Reports, Vol. 9, Iss. 2, 2014-01 ,pp. : 645-652

Spandidos Publications

Access to resources Recommend Favorite